Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (November 1993). «Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase». The Journal of Biological Chemistry268 (31): 23422-6. PMID8226867. doi:10.1016/S0021-9258(19)49479-9.
Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N (December 2007). «5-HT7 receptor antagonists as a new class of antidepressants». Drug News & Perspectives20 (10): 613-8. PMID18301795. doi:10.1358/dnp.2007.20.10.1181354.
Heidmann DE, Metcalf MA, Kohen R, Hamblin MW (April 1997). «Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization». Journal of Neurochemistry68 (4): 1372-81. PMID9084407. doi:10.1046/j.1471-4159.1997.68041372.x.
Krobert KA, Bach T, Syversveen T, Kvingedal AM, Levy FO (June 2001). «The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution». Naunyn-Schmiedeberg's Archives of Pharmacology363 (6): 620-32. PMID11414657. doi:10.1007/s002100000369.
Kim Y, Kim H, Lee J, Lee JK, Min SJ, Seong J, Rhim H, Tae J, Lee HJ, Choo H (August 2018). «Discovery of β-Arrestin Biased Ligands of 5-HT7R». J. Med. Chem.61 (16): 7218-7233. PMID30028132. doi:10.1021/acs.jmedchem.8b00642.
Sprouse J, Reynolds L, Li X, Braselton J, Schmidt A (January 2004). «8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production». Neuropharmacology46 (1): 52-62. PMID14654097. S2CID41623573. doi:10.1016/j.neuropharm.2003.08.007.
Brenchat A, Ejarque M, Zamanillo D, Vela JM, Romero L (August 2011). «Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors». Journal of Pharmacological Sciences116 (4): 388-91. PMID21778664. doi:10.1254/jphs.11039sc.
Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM (June 2010). «Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity». Pain149 (3): 483-94. PMID20399562. S2CID16613426. doi:10.1016/j.pain.2010.03.007.
Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM (February 2009). «5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice». Pain141 (3): 239-47. PMID19118950. S2CID27144262. doi:10.1016/j.pain.2008.11.009.
Leopoldo M, Lacivita E, Contino M, Colabufo NA, Berardi F, Perrone R (August 2007). «Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2». Journal of Medicinal Chemistry50 (17): 4214-21. PMID17649988. doi:10.1021/jm070487n.
Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V (December 2004). «Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents». Journal of Medicinal Chemistry47 (26): 6616-24. PMID15588097. doi:10.1021/jm049702f.
Hogendorf AS, Hogendorf A, Popiolek-Barczyk K, Ciechanowska A, Mika J, Satała G, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Ponimaskin E, Schade S, Zeug A, Bijata M, Kubicki M, Kurczab R, Lenda T, Staroń J, Kurczab R, Satała G, Lenda T, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Wierońska JM, Woźniak M, Cieślik P, Bugno R, Staroń J, Bugno R, Duszyńska B, Pilarski B, Bojarski AJ (2019). «Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers». European Journal of Medicinal Chemistry170: 261-275. PMID30904783. S2CID85498356. doi:10.1016/j.ejmech.2019.03.017.
Pittalà V, Salerno L, Modica M, Siracusa MA, Romeo G (September 2007). «5-HT7 receptor ligands: recent developments and potential therapeutic applications». Mini Reviews in Medicinal Chemistry7 (9): 945-60. PMID17897083. doi:10.2174/138955707781662663.
Leopoldo M (March 2004). «Serotonin(7) receptors (5-HT(7)Rs) and their ligands». Current Medicinal Chemistry11 (5): 629-61. PMID15032609. doi:10.2174/0929867043455828.
Volk B, Barkóczy J, Hegedus E, Udvari S, Gacsályi I, Mezei T, Pallagi K, Kompagne H, Lévay G, Egyed A, Hársing LG, Spedding M, Simig G (April 2008). «(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists». Journal of Medicinal Chemistry51 (8): 2522-32. PMID18361484. doi:10.1021/jm070279v.
Lacivita E, Patarnello D, Stroth N, Caroli A, Niso M, Contino M, De Giorgio P, Di Pilato P, Colabufo NA, Berardi F, Perrone R, Svenningsson P, Hedlund PB, Leopoldo M (2012). «Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin7 (5-HT7) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo». Journal of Medicinal Chemistry55 (14): 6375-6380. PMID22738316. doi:10.1021/jm3003679.
Romero G, Pujol M, Pauwels PJ (October 2006). «Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists». Naunyn-Schmiedeberg's Archives of Pharmacology374 (1): 31-9. PMID16967291. S2CID25203956. doi:10.1007/s00210-006-0093-y.
Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N (February 1998). «(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist». Journal of Medicinal Chemistry41 (5): 655-7. PMID9513592. doi:10.1021/jm970519e.
Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (July 2004). «Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors». European Journal of Pharmacology495 (2–3): 97-102. PMID15249157. doi:10.1016/j.ejphar.2004.05.033.
Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR (February 2000). «A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970)». Journal of Medicinal Chemistry43 (3): 342-5. PMID10669560. doi:10.1021/jm991151j.
Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR (November 2002). «SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties». Bioorganic & Medicinal Chemistry Letters12 (22): 3341-4. PMID12392747. doi:10.1016/S0960-894X(02)00690-X.
Smith C, Rahman T, Toohey N, Mazurkiewicz J, Herrick-Davis K, Teitler M (October 2006). «Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor». Molecular Pharmacology70 (4): 1264-70. PMID16870886. doi:10.1124/mol.106.024612.
Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (November 1993). «Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase». The Journal of Biological Chemistry268 (31): 23422-6. PMID8226867. doi:10.1016/S0021-9258(19)49479-9.
Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N (December 2007). «5-HT7 receptor antagonists as a new class of antidepressants». Drug News & Perspectives20 (10): 613-8. PMID18301795. doi:10.1358/dnp.2007.20.10.1181354.
Heidmann DE, Metcalf MA, Kohen R, Hamblin MW (April 1997). «Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization». Journal of Neurochemistry68 (4): 1372-81. PMID9084407. doi:10.1046/j.1471-4159.1997.68041372.x.
Krobert KA, Bach T, Syversveen T, Kvingedal AM, Levy FO (June 2001). «The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution». Naunyn-Schmiedeberg's Archives of Pharmacology363 (6): 620-32. PMID11414657. doi:10.1007/s002100000369.
Kim Y, Kim H, Lee J, Lee JK, Min SJ, Seong J, Rhim H, Tae J, Lee HJ, Choo H (August 2018). «Discovery of β-Arrestin Biased Ligands of 5-HT7R». J. Med. Chem.61 (16): 7218-7233. PMID30028132. doi:10.1021/acs.jmedchem.8b00642.
Sprouse J, Reynolds L, Li X, Braselton J, Schmidt A (January 2004). «8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production». Neuropharmacology46 (1): 52-62. PMID14654097. S2CID41623573. doi:10.1016/j.neuropharm.2003.08.007.
Brenchat A, Ejarque M, Zamanillo D, Vela JM, Romero L (August 2011). «Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors». Journal of Pharmacological Sciences116 (4): 388-91. PMID21778664. doi:10.1254/jphs.11039sc.
Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM (June 2010). «Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity». Pain149 (3): 483-94. PMID20399562. S2CID16613426. doi:10.1016/j.pain.2010.03.007.
Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM (February 2009). «5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice». Pain141 (3): 239-47. PMID19118950. S2CID27144262. doi:10.1016/j.pain.2008.11.009.
Leopoldo M, Lacivita E, Contino M, Colabufo NA, Berardi F, Perrone R (August 2007). «Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2». Journal of Medicinal Chemistry50 (17): 4214-21. PMID17649988. doi:10.1021/jm070487n.
Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V (December 2004). «Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents». Journal of Medicinal Chemistry47 (26): 6616-24. PMID15588097. doi:10.1021/jm049702f.
Hogendorf AS, Hogendorf A, Popiolek-Barczyk K, Ciechanowska A, Mika J, Satała G, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Ponimaskin E, Schade S, Zeug A, Bijata M, Kubicki M, Kurczab R, Lenda T, Staroń J, Kurczab R, Satała G, Lenda T, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Wierońska JM, Woźniak M, Cieślik P, Bugno R, Staroń J, Bugno R, Duszyńska B, Pilarski B, Bojarski AJ (2019). «Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers». European Journal of Medicinal Chemistry170: 261-275. PMID30904783. S2CID85498356. doi:10.1016/j.ejmech.2019.03.017.
Pittalà V, Salerno L, Modica M, Siracusa MA, Romeo G (September 2007). «5-HT7 receptor ligands: recent developments and potential therapeutic applications». Mini Reviews in Medicinal Chemistry7 (9): 945-60. PMID17897083. doi:10.2174/138955707781662663.
Leopoldo M (March 2004). «Serotonin(7) receptors (5-HT(7)Rs) and their ligands». Current Medicinal Chemistry11 (5): 629-61. PMID15032609. doi:10.2174/0929867043455828.
Volk B, Barkóczy J, Hegedus E, Udvari S, Gacsályi I, Mezei T, Pallagi K, Kompagne H, Lévay G, Egyed A, Hársing LG, Spedding M, Simig G (April 2008). «(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists». Journal of Medicinal Chemistry51 (8): 2522-32. PMID18361484. doi:10.1021/jm070279v.
Lacivita E, Patarnello D, Stroth N, Caroli A, Niso M, Contino M, De Giorgio P, Di Pilato P, Colabufo NA, Berardi F, Perrone R, Svenningsson P, Hedlund PB, Leopoldo M (2012). «Investigations on the 1-(2-Biphenyl)piperazine Motif: Identification of New Potent and Selective Ligands for the Serotonin7 (5-HT7) Receptor with Agonist or Antagonist Action in Vitro or ex Vivo». Journal of Medicinal Chemistry55 (14): 6375-6380. PMID22738316. doi:10.1021/jm3003679.
Romero G, Pujol M, Pauwels PJ (October 2006). «Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists». Naunyn-Schmiedeberg's Archives of Pharmacology374 (1): 31-9. PMID16967291. S2CID25203956. doi:10.1007/s00210-006-0093-y.
Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N (February 1998). «(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist». Journal of Medicinal Chemistry41 (5): 655-7. PMID9513592. doi:10.1021/jm970519e.
Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (July 2004). «Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors». European Journal of Pharmacology495 (2–3): 97-102. PMID15249157. doi:10.1016/j.ejphar.2004.05.033.
Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR (February 2000). «A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970)». Journal of Medicinal Chemistry43 (3): 342-5. PMID10669560. doi:10.1021/jm991151j.
Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR (November 2002). «SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties». Bioorganic & Medicinal Chemistry Letters12 (22): 3341-4. PMID12392747. doi:10.1016/S0960-894X(02)00690-X.
Zhang J, Ferguson SS, Barak LS, Aber MJ, Giros B, Lefkowitz RJ, Caron MG (1997). «Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization». Receptors & Channels5 (3–4): 193-9. PMID9606723.
Smith C, Rahman T, Toohey N, Mazurkiewicz J, Herrick-Davis K, Teitler M (October 2006). «Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor». Molecular Pharmacology70 (4): 1264-70. PMID16870886. doi:10.1124/mol.106.024612.
Sprouse J, Reynolds L, Li X, Braselton J, Schmidt A (January 2004). «8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production». Neuropharmacology46 (1): 52-62. PMID14654097. S2CID41623573. doi:10.1016/j.neuropharm.2003.08.007.
Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM (June 2010). «Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity». Pain149 (3): 483-94. PMID20399562. S2CID16613426. doi:10.1016/j.pain.2010.03.007.
Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM (February 2009). «5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice». Pain141 (3): 239-47. PMID19118950. S2CID27144262. doi:10.1016/j.pain.2008.11.009.
Hogendorf AS, Hogendorf A, Popiolek-Barczyk K, Ciechanowska A, Mika J, Satała G, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Ponimaskin E, Schade S, Zeug A, Bijata M, Kubicki M, Kurczab R, Lenda T, Staroń J, Kurczab R, Satała G, Lenda T, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Wierońska JM, Woźniak M, Cieślik P, Bugno R, Staroń J, Bugno R, Duszyńska B, Pilarski B, Bojarski AJ (2019). «Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers». European Journal of Medicinal Chemistry170: 261-275. PMID30904783. S2CID85498356. doi:10.1016/j.ejmech.2019.03.017.
Romero G, Pujol M, Pauwels PJ (October 2006). «Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists». Naunyn-Schmiedeberg's Archives of Pharmacology374 (1): 31-9. PMID16967291. S2CID25203956. doi:10.1007/s00210-006-0093-y.
